Long-lived autoreactive plasma cells drive persistent autoimmune inflammation. Long-lived plasma cells are not sufficiently eliminated by current therapies, these findings are extremely relevant to the development of novel concepts for the treatment of autoimmune diseases. Thus, long-lived plasma cells appear to be a promising new therapeutic target. Hiepe F Nat Rev Rheumatol. 2011 Feb 1. (Also see: Causes of Autoimmunity)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
ISN Assistant News Guide
International Scleroderma Network(ISN)
Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
No replies to this topic